Corticotropin-releasing factor requires CRF binding protein to potentiate NMDA receptors via CRF receptor 2 in dopamine neurons

被引:243
作者
Ungless, MA
Singh, V
Crowder, TL
Yaka, R
Ron, D
Bonci, A [1 ]
机构
[1] Univ Calif San Francisco, Ernest Gallo Clin & Res Ctr, San Francisco, CA 94110 USA
[2] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94110 USA
[3] Univ Calif San Francisco, Wheeler Ctr Neurobiol Addict, San Francisco, CA 94110 USA
关键词
D O I
10.1016/S0896-6273(03)00461-6
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Stress increases addictive behaviors and is a common cause of relapse. Corticotropin-releasing factor (CRF) plays a key role in the modulation of drug taking by stress. However, the mechanism by which CRF modulates neuronal activity in circuits involved in drug addiction is poorly understood. Here we show that CRF induces a potentiation of NMDAR (N-methyl-D-aspartate receptor)-mediated synaptic transmission in dopamine neurons of the ventral tegmental area (VTA). This effect involves CRF receptor 2 (CRF-R2) and activation of the phospholipase C (PLC)-protein kinase C (PKC) pathway. We also find that this potentiation requires CRF binding protein (CRF-BP). Accordingly, CRF-like peptides, which do not bind the CRF-BP with high affinity, do not potentiate NMDARs. These results provide evidence of the first specific roles for CRF-R2 and CRF-BP in the modulation of neuronal activity and suggest that NMDARs in the VTA may be a target for both drugs of abuse and stress.
引用
收藏
页码:401 / 407
页数:7
相关论文
共 37 条
[11]   Activation of ventral tegmental area cells by the bed nucleus of the stria terminalis: A novel excitatory amino acid input to midbrain dopamine neurons [J].
Georges, F ;
Aston-Jones, G .
JOURNAL OF NEUROSCIENCE, 2002, 22 (12) :5173-5187
[12]   Corticotropin-releasing factor-binding protein ligand inhibitor blunts excessive weight gain in genetically obese Zucker rats and rats during nicotine withdrawal [J].
Heinrichs, SC ;
Lapsansky, J ;
Behan, DP ;
Chan, RKW ;
Sawchenko, PE ;
Lorang, M ;
Ling, N ;
Vale, WW ;
DeSouza, EB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (26) :15475-15480
[13]   Dissociation of arousal-like from anxiogenic-like actions of brain corticotropin-releasing factor receptor ligands in rats [J].
Heinrichs, SC ;
Joppa, M .
BEHAVIOURAL BRAIN RESEARCH, 2001, 122 (01) :43-50
[14]   The binding protein of corticotropin-releasing factor: Ligand-binding site and subunit structure [J].
Jahn, O ;
Eckart, K ;
Brauns, O ;
Tezval, H ;
Spiess, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (19) :12055-12060
[15]   The corticotrophin-releasing factor-binding protein: An act of several parts [J].
Kemp, CF ;
Woods, RJ ;
Lowry, PJ .
PEPTIDES, 1998, 19 (06) :1119-1128
[16]   A role for corticotropin releasing factor and urocortin in behavioral responses to stressors [J].
Koob, GF ;
Heinrichs, SC .
BRAIN RESEARCH, 1999, 848 (1-2) :141-152
[17]   CORTICOTROPIN-RELEASING HORMONE (CRH)-BINDING PROTEIN - REDUCTION IN THE ADRENOCORTICOTROPIN-RELEASING ACTIVITY OF PLACENTAL BUT NOT HYPOTHALAMIC CRH [J].
LINTON, EA ;
BEHAN, DP ;
SAPHIER, PW ;
LOWRY, PJ .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1990, 70 (06) :1574-1580
[18]   CLONING AND CHARACTERIZATION OF A FUNCTIONALLY DISTINCT CORTICOTROPIN-RELEASING FACTOR-RECEPTOR SUBTYPE FROM RAT-BRAIN [J].
LOVENBERG, TW ;
LIAW, CW ;
GRIGORIADIS, DE ;
CLEVENGER, W ;
CHALMERS, DT ;
DESOUZA, EB ;
OLTERSDORF, T .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (03) :836-840
[19]   Nature of ligand affinity and dimerization of corticotrophin-releasing factor-binding protein may be detected by circular dichroism [J].
Lowry, PJ ;
Koerber, SC ;
Woods, RJ ;
Baigent, S ;
Sutton, S ;
Behan, DP ;
Vale, W ;
Rivier, J .
JOURNAL OF MOLECULAR ENDOCRINOLOGY, 1996, 16 (01) :39-44
[20]   STRESS ACTIVATION OF MESOCORTICOLIMBIC DOPAMINE NEURONS - EFFECTS OF A GLYCINE NMDA RECEPTOR ANTAGONIST [J].
MORROW, BA ;
CLARK, WA ;
ROTH, RH .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1993, 238 (2-3) :255-262